Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...
LONDON--(BUSINESS WIRE)--The global mycoplasma testing market size is expected to grow by USD 445.57 million as per Technavio. This marks a significant market growth compared to the 2019 growth ...
Eurofins Lancaster Laboratories has launched a new validated Rapid Mycoplasma Detection Test, overcoming time-consuming challenges of the standard 28-day compendial method for mycoplasma testing. For ...
Often referred to as “walking pneumonia”, M. pneumoniae has been associated with up to 40% of community-acquired pneumonias. Infection occurs in both children and adults without geographical, gender ...
Furthermore, a product developed with mycoplasma contamination triggers serious side effects in humans. Rapid mycoplasma test kits are commercially available in the market that can be used in research ...
The discovery of mycoplasma contaminants in cell culture and the subsequent biologicals is vital because of the negatives effects mycoplasma has on the physiology of cells. The contamination of ...
United States Data Bridge Market Research conducted an extensive qualitative study focusing on the “Mycoplasma Testing in Clinical Market“. Mycoplasma Testing in Clinical market research report lends ...
Mycoplasma pneumonia gets its nickname because symptoms, including persistent cough, are mild enough for most people to avoid being bedridden.
The US Food and Drug Administration (FDA) has approved the Aptima Mycoplasma genitalium Assay from Hologic Inc, the first and only FDA-approved test to aid in the diagnosis of this sexually ...